Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Przemyslaw Twardowski
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
214 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Arizona Medical Center-University Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente Hospital
Fontana, California, United States
- Kaiser Permanente - Harbor City
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente-Cadillac
Los Angeles, California, United States
- Los Angeles County-Usc Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Sutter Cancer Research Consortium
Novato, California, United States
- Stanford Cancer Institute
Palo Alto, California, United States
- Kaiser Permanente - Panorama City
Panorama City, California, United States
- Kaiser Permanente-Riverside
Riverside, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Kaiser Permanente-San Diego Mission
San Diego, California, United States
- Kaiser Permanente-San Diego Zion
San Diego, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Kaiser Permanente-San Marcos
San Marcos, California, United States
- Sutter Pacific Medical Foundation
Santa Rosa, California, United States
- Gene Upshaw Memorial Tahoe Forest Cancer Center
Truckee, California, United States
- Sutter Solano Medical Center/cancer Center
Vallejo, California, United States
- Kaiser Permanente
Woodland Hills, California, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- George Washington University Medical Center
Washington D.C., District of Columbia, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Idaho Urologic Institute-Meridian
Meridian, Idaho, United States
- Hematology and Oncology Associates
Chicago, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Aug 2012
- Primary completion
- 30 Apr 2017
- Completion
- 30 Apr 2017
- Last update posted
- 3 Jan 2019
- Registered enrollment
- 55
- Registry id
- NCT01688973
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.